By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Mission Therapeutics Ltd 

Meditrina (Building 260)
Babraham Reseach Campus
  Cambridge  CB22 3AT  United Kingdom
Phone: n/a Fax: n/a




Company News
Mission Therapeutics Snags $86.37 Million to Progress Development of Novel DUB Inhibitors from Innovative Drug Platform 2/2/2016 5:45:58 AM
Mission Therapeutics Ltd Appoints David Luther As Chief Financial Officer 10/1/2015 10:37:01 AM
Mission Therapeutics Ltd Receives Funding From Innovate UK For DUB Cancer Programme 9/22/2015 9:25:40 AM
Mission Therapeutics Ltd Expands Management Team 9/1/2015 9:24:43 AM
Mission Therapeutics Ltd Appoints Dr Colin Goddard To Its Board Of Directors 7/1/2015 10:05:50 AM
Mission Therapeutics Ltd Presents At The Annual Meeting Of AACR The Identification Of Novel Inhibitors Of The UCHL1 Oncogene 4/20/2015 2:54:26 PM
Mission Therapeutics Ltd Appoints Paul Wallace As Chief Business Officer 3/16/2015 10:34:56 AM
MissionTherapeutics Ltd Appoints Anker Lundemose As Chief Executive Officer 1/9/2015 9:59:32 AM
Pfizer Inc. (PFE) Sees Something Special In MissionTherapeutics Ltd, Backs Co With $32 Million Series B 11/18/2013 8:27:42 AM
MissionTherapeutics Ltd Co-Founder and CSO Becomes an Associate Faculty Member at the Wellcome Trust Sanger Institute 4/8/2013 11:28:52 AM